D
Enliven Therapeutics, Inc. ELVN
$20.32 $0.3751.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 7.09M 6.80M 6.17M 5.81M 5.78M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 28.58M 31.69M 26.90M 27.07M 24.60M
Operating Income -28.58M -31.69M -26.90M -27.07M -24.60M
Income Before Tax -25.34M -28.54M -23.18M -23.16M -19.72M
Income Tax Expenses -- -- 0.00 -- 232.00K
Earnings from Continuing Operations -25.34M -28.54M -23.18M -23.16M -19.95M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -25.34M -28.54M -23.18M -23.16M -19.95M
EBIT -28.58M -31.69M -26.90M -27.07M -24.60M
EBITDA -28.50M -31.62M -26.82M -26.99M -24.53M
EPS Basic -0.49 -0.57 -0.46 -0.48 -0.42
Normalized Basic EPS -0.30 -0.36 -0.30 -0.30 -0.27
EPS Diluted -0.49 -0.57 -0.46 -0.48 -0.42
Normalized Diluted EPS -0.30 -0.36 -0.30 -0.30 -0.27
Average Basic Shares Outstanding 52.11M 50.05M 49.86M 48.27M 48.08M
Average Diluted Shares Outstanding 52.11M 50.05M 49.86M 48.27M 48.08M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --